ALAQAR | AL-`AQAR HEALTHCARE REIT

1.37 (0.0%)
1

T-O (am): 0.000 (08:59:00)
Last updated: 17:00

Fundamental
Technical
Total Score
ALAQAR | AL-`AQAR HEALTHCARE REIT

ALAQAR Support & Resistance

ATR Trailing Stop: 1.37

Support
Last Price
Resistance
Price 1.32 1.34 1.35 1.36 1.37 1.37 1.37 1.38 1.39 1.4 1.41
Volume (M) 77.4 66.3 60.7 36.7 51.3 51.3 44.0 46.3 73.4 35.7

Gann Support: 1.33/1.27 | Resistance: 1.39/1.45

*Highlighted column shows significant volume at the support or resistance area.

ALAQAR Technical Trend

ALAQAR Trading Signals

Based on iSaham Screeners

Moving Average (Short Term)
Moving Average (Mid Term)
Moving Average (Long Term)
Ichimoku Kumo
Bollinger Band
RSI
Stochastic
Heikin-Ashi
MACD
Solid MA Trend
SAT
Sector Trend (Long Term)
Sector Trend (Short Term)
Institutional Holdings
Beat The Insti
Magic Formula
Better Than ASB
52-Week High
BTST
T+
Candlestick
Chart Pattern

Please be fully informed regarding the risks and costs associated with trading in the stock markets. Any trade you made must be followed by your own judgement and analysis. Please read our risk disclosure for more info.

ALAQAR Pivot Point

S2
S1
P
R1
R2
Daily 1.36 1.37 1.37 1.38 1.38
Weekly 1.34 1.35 1.38 1.39 1.42

ALAQAR Fundamental Trend

FCON: | Sharpe Ratio: | LTS:


Chart:

ALAQAR Quarter Reports

Select columns required and click "Update" to save your preferences

Ann. Date Qtr. Date Q FYE Revenue [M] PBT [M] NP [M] NPM DPS EPS R. QoQ R. YoY E. QoQ E. YoY TTM
EPS		 Adj.
[M]		 NP [M]
(adj)		 NPM
(adj)		 EPS
(adj)		 E. QoQ
(adj)		 E. YoY
(adj)		 TTM EPS
(adj)
29 Aug 24 Q2 Jun 24 2 31 Dec 24 29.39 16.36 16.36 55.6% 1.90 1.95 1.5% 0.0% 0.3% 6.7%
24 May 24 Q1 Mar 24 1 31 Dec 24 29.84 16.41 16.41 55.0% 1.90 1.95 2.6% 1.2% 56.0% 5.0%
22 Feb 24 Q4 Dec 23 4 31 Dec 23 30.63 10.38 10.52 34.3% 2.00 1.29 0.5% 8.4% 40.2% 101.3%
24 Nov 23 Q3 Sep 23 3 31 Dec 23 30.79 17.59 17.59 57.1% 2.00 2.18 4.7% 12.3% 14.8% 0.2%
25 Aug 23 Q2 Jun 23 2 31 Dec 23 29.39 15.32 15.32 52.1% 1.90 1.94 2.7% 7.6% 11.3% 16.5%
26 May 23 Q1 Mar 23 1 31 Dec 23 30.21 17.27 17.27 57.1% 2.00 2.28 6.9% 10.9% 230.5% 8.9%
24 Feb 23 Q4 Dec 22 4 31 Dec 22 28.26 5.12 5.22 18.5% 2.10 0.71 3.0% 4.8% 70.3% 77.2%
25 Nov 22 Q3 Sep 22 3 31 Dec 22 27.42 17.62 17.62 64.2% 2.00 2.39 0.4% 4.4% 3.9% 15.3%
26 Aug 22 Q2 Jun 22 2 31 Dec 22 27.31 18.34 18.34 67.2% 2.00 2.49 0.2% 6.7% 3.2% 2.3%
30 May 22 Q1 Mar 22 1 31 Dec 22 27.25 18.95 18.95 69.6% 2.00 2.58 1.0% 6.5% 17.2% 8.6%
28 Feb 22 Q4 Dec 21 4 31 Dec 21 26.97 22.11 22.88 84.8% 1.80 3.11 5.9% 13.7% 49.7% 184.4%
26 Nov 21 Q3 Sep 21 3 31 Dec 21 28.67 15.29 15.29 53.3% 2.00 2.07 2.0% 13.2% 14.8% 12.1%
26 Aug 21 Q2 Jun 21 2 31 Dec 21 29.27 17.93 17.93 61.3% 2.00 2.44 0.4% 38.3% 2.8% 69.9%
28 May 21 Q1 Mar 21 1 31 Dec 21 29.16 17.45 17.45 59.9% 3.45 2.37 6.7% 3.5% 164.3% 12.6%
19 Feb 21 Q4 Dec 20 4 31 Dec 20 31.25 -26.07 -27.12 -86.8% 1.30 -3.68 23.3% 17.1% 298.9% 194.0%
26 Nov 20 Q3 Sep 20 3 31 Dec 20 25.34 13.63 13.63 53.8% 2.06 1.85 19.7% 5.2% 29.2% 15.5%
28 Aug 20 Q2 Jun 20 2 31 Dec 20 21.16 10.56 10.56 49.9% 0.00 1.43 24.9% 19.4% 31.9% 30.6%
29 May 20 Q1 Mar 20 1 31 Dec 20 28.16 15.51 15.51 55.1% 2.02 2.11 5.6% 6.5% 46.2% 2.9%
25 Feb 20 Q4 Dec 19 4 31 Dec 19 26.68 28.83 28.85 108.1% 1.96 3.92 0.1% 3.0% 78.9% 34.5%
21 Nov 19 Q3 Sep 19 3 31 Dec 19 26.72 16.13 16.13 60.4% 1.86 2.19 1.7% 4.3% 6.0% 6.5%
30 Aug 19 Q2 Jun 19 2 31 Dec 19 26.27 15.22 15.22 58.0% 1.91 2.07 0.7% 2.7% 4.6% 1.4%
29 May 19 Q1 Mar 19 1 31 Dec 19 26.45 15.96 15.96 60.4% 2.07 2.17 2.1% 3.5% 63.8% 4.7%
20 Feb 19 Q4 Dec 18 4 31 Dec 18 25.90 44.97 44.05 170.1% 1.93 6.04 1.1% 4.5% 190.9% 16.0%
30 Nov 18 Q3 Sep 18 3 31 Dec 18 25.62 15.14 15.14 59.1% 1.95 2.08 0.1% 2.4% 2.0% 12.2%
29 Aug 18 Q2 Jun 18 2 31 Dec 18 25.59 15.46 15.45 60.4% 1.75 2.12 0.2% 2.6% 7.8% 7.2%
24 May 18 Q1 Mar 18 1 31 Dec 18 25.55 16.74 16.74 65.5% 3.95 2.30 3.1% 2.6% 55.9% 11.4%
21 Feb 18 Q4 Dec 17 4 31 Dec 17 24.78 38.88 37.98 153.3% 0.00 5.21 1.0% 1.3% 120.3% 154.9%
23 Nov 17 Q3 Sep 17 3 31 Dec 17 25.02 17.24 17.24 68.9% 3.75 2.37 0.3% 2.9% 19.7% 9.5%
24 Aug 17 Q2 Jun 17 2 31 Dec 17 24.94 15.01 14.40 57.7% 0.00 1.98 0.2% 6.1% 4.2% 12.5%
23 May 17 Q1 Mar 17 1 31 Dec 17 24.90 15.03 15.03 60.3% 3.80 2.06 0.8% 5.7% 0.8% 8.0%
15 Feb 17 Q4 Dec 16 4 31 Dec 16 25.10 15.45 14.90 59.4% 0.00 2.04 2.6% 11.0% 5.3% 31.5%
29 Nov 16 Q3 Sep 16 3 31 Dec 16 25.77 15.74 15.74 61.1% 3.90 2.16 2.9% 6.6% 4.4% 4.2%
22 Aug 16 Q2 Jun 16 2 31 Dec 16 26.55 16.46 16.46 62.0% 0.00 2.26 0.5% 3.8% 0.8% 7.8%
20 May 16 Q1 Mar 16 1 31 Dec 16 26.41 16.34 16.34 61.8% 2.53 2.24 6.3% 4.2% 24.9% 6.6%
25 Feb 16 Q4 Dec 15 4 31 Dec 15 28.20 21.66 21.75 77.2% 5.17 3.07 2.2% 3.9% 44.1% 19.3%
26 Nov 15 Q3 Sep 15 3 31 Dec 15 27.59 15.29 15.10 54.7% 5.17 2.17 0.0% 1.3% 1.1% 2.2%
25 Aug 15 Q2 Jun 15 2 31 Dec 15 27.59 15.46 15.27 55.3% 3.79 2.19 0.1% 1.7% 0.4% 4.3%
28 May 15 Q1 Mar 15 1 31 Dec 15 27.57 15.51 15.32 55.6% 3.79 2.20 1.5% 1.6% 43.2% 3.4%
27 Feb 15 31/12/14 4 31/12/14 27.15 28.27 26.97 99.3% 3.86 3.87 0.3% 1.2% 82.5% 13.2%

ALAQAR Historical Dividends

ALAQAR Financial Ratios

EPS 7.25 sen
Trailing PE (Sector Median: 13.7) 18.9
PEG 2.95
Altman Z 0.2
Beaver 0.024
Current Ratio 1.53
Debt-Equity (DE) Ratio 0.0
FCF Yield 1.77 %
Revenue QoQ -1.5 %
Revenue YoY 0.01%
Profit QoQ -0.33 %
Profit YoY 6.74 %
Profit Margin (Sector Median: 25.7) 50.45 %
ROE (ROIC: 0.0) 0.0 %
Dividend Per Share (DPS) 7.8 sen
Dividend Yield (DY) 5.69 %

ALAQAR Adjusted Financial Ratios

Ratios below have been recalculated after adjusting for One Off Gain/Loss detected from Quarterly reports

EPS
Trailing PE (Sector Median: 13.7)
Profit QoQ
Profit YoY
Profit Margin (Sector Median: 25.7)
ROE (ROIC: 0.0)
Altman Z

ALAQAR Fair Value

Weighted Average Fair Value:

Discounted Cash Flow (DCF) 5% Growth
Discounted Cash Flow (DCF) 10% Growth
Relative Valuation
Average Analysts FV based on 1 rating(s)
Graham Formula
Graham Number
Net Tangible Asset (NTA) 1.28
Consistent QR FV
The Fair Value numbers are not, and must not be construed to be, any recommendation, offer or invitation to buy or sell any securities, futures contracts or any other instrument. The figures shown here should be taken as educational purposes only

Advanced Calculators

Calculate the fair value of the stock based on expected growth / risk, contract / award value, forecasted profit or forecasted revenue.

Forward PE FV Calculator
Latest Profit (adjusted) [M] 16.36
Expected Profit (Next QR) [M]
Expected Profit (After QR above) [M]
Expected Profit (After QR above) [M]
Estimated Fair Value
Growth/Risk Fair Value Calculator
Expected growth (%)
Estimated downside / risk (%)
Estimated New DCF Fair Value
Contract/Award Contribution Calculator
Contract/Award Value (in Million)
Estimated Contribution to Stock Price
Estimated New DCF Fair Value
Profit-Based Calculator
Expected Profit (M)
for Year
Estimated New DCF Fair Value
Revenue-Based Calculator
Expected Revenue (M)
for Year
Estimated New DCF Fair Value
Market Pricing
Expected Profit (M) 167.59
Expected Revenue (M) 324.54
Expected Growth (%) 20.0
The Fair Value calculated using this calculators are not, and must not be construed to be, any recommendation, offer or invitation to buy or sell any securities, futures contracts or any other instrument. The purpose of this tool is to help investor to quickly calculate their own expected Fair Value based on their own research

ALAQAR Directors Share Purchases (Beta)


No transaction in the last 2 months.

ALAQAR Summary


Market Cap: 1150 M.

Market Cap Class: Middlers

Number of Shares: 839 M.

Adjusted Float: 55.6%.

Stock highly correlated with

ABMB (86%)

IGBREIT (85%)

IHH (85%)

QL (84%)

Al-‘Aqar Healthcare REIT is a Malaysian-based real estate and investment trust, established on 28 June 2006 under the execution of a Trust Deed dated 27 June 2006 between the Manager (“DRMSB”), and the Trustee (“AmanahRaya Trustees Berhad”). It was listed on the Main Board of Bursa Malaysia on 10 August 2006.

Sectors: REITs

Share Registrar: LARKIN SENTRAL PROPERTY BERHAD

Code: 5116

Website: http://www.alaqar.com.my/

Related Links: Bursa | Annual Report | Announcement

Warrant Info:

No warrants listed

ALAQAR Top Shareholdings

Updated on 29-Dec-2023

Shareholder % Value (M)
Tabung Haji 14.31% 164.6
Employees Provident Fund Board 13.27% 152.64
KWAP 7.53% 86.61
Pusat Pakar Tawakal Sdn Bhd 7.1% 81.67
Amanah Saham Bumiputera 6.88% 79.14
Bandar Baru Klang Specialist Hospital Sdn Bhd 4.3% 49.46
Selangor Specialist Hospital Sdn. Bhd. 4.17% 47.97
KPJ Healthcare Berhad 3.37% 38.76
Seremban Specialist Hospital Sdn Bhd 2.83% 32.55
Ampang Puteri Specialist Hospital Sdn Bhd 2.5% 28.76
Medical Associates Sdn Bhd 2.27% 26.11
Waqaf An-Nur Corporation Berhad 2.17% 24.96
Amanah Saham Malaysia 2.01% 23.12
Sentosa Medical Centre Sdn Bhd 1.86% 21.39
Kedah Medical Centre Sdn Bhd 1.79% 20.59
Public Islamic Opportunities Fund 1.62% 18.63
Prudential BSN Fund 1.62% 18.63
Johor Specialist Hospital Sdn Bhd 1.45% 16.68
Puteri Specialist Hospital (Johor) Sdn Bhd 1.43% 16.45
Perdana Specialist Hospital Sdn Bhd 1.43% 16.45
Public Mutual Fund 1.4% 16.1
Prulink Dana Unggul 0.66% 7.59
Kuantan Specialist Hospital Sdn Bhd 0.6% 6.9
Kajang Specialist Hospital Sdn. Bhd. 0.53% 6.1
Ong Ah How @ Ong Beng Hwa 0.5% 5.75
Jeta Gardens (QLD) Pty Ltd 0.45% 5.18
This calculator uses Malacca Securities (M+) cash upfront rate (min RM 8 or 0.08%) for all brokerage fee calculation.
This calculator uses Malacca Securities (M+) cash upfront rate (min RM 8 or 0.08%) for all brokerage fee calculation.